FBXO10 activators belong to a specific category of chemical compounds that are designed to modulate the activity of the FBXO10 protein. FBXO10, a member of the F-box protein family, plays a crucial role in the ubiquitin-proteasome system, a fundamental cellular process responsible for the controlled degradation of proteins. The ubiquitin-proteasome system is essential for regulating various cellular functions, including cell cycle progression, signal transduction, and protein turnover. FBXO10 itself functions as a substrate recognition component of the Skp1-Cullin1-F-box (SCF) ubiquitin ligase complex, which is responsible for tagging specific proteins for degradation by attaching ubiquitin molecules to them. FBXO10 activators, by definition, are chemical compounds that enhance or promote the function of FBXO10, ultimately influencing the degradation of specific protein targets.
These activators can act through various mechanisms, such as stabilizing FBXO10's interaction with its protein targets or enhancing its catalytic activity in ubiquitinating target proteins. The precise molecular mechanisms of FBXO10 activation can vary depending on the specific compound, but the overarching goal is to fine-tune the regulation of protein levels within the cell. This modulation can have significant implications for various cellular processes, including cell growth, differentiation, and response to external signals. The development and study of FBXO10 activators are of great interest in the field of molecular biology and cell biology, as they provide a means to manipulate the degradation of specific proteins, potentially shedding light on their roles in various physiological and pathological conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibits the NEDD8-activating enzyme (NAE), thereby increasing the activation of Cullin-RING ligases (CRLs), including FBXO10. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Activates FBXO10 indirectly by suppressing the mTOR pathway, which intersects with the SCF complex. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
Upregulates FBXO10 activity by inhibiting GSK-3, a regulator of various cellular processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Increases FBXO10 activity indirectly by suppressing the PI3K/Akt/mTOR pathway, which intersects with the SCF complex. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Upregulates FBXO10 by inhibiting p38 MAPK and influencing the MAPK pathway, which intersects with the SCF complex. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Activates FBXO10 indirectly by altering protein stability; Hsp90 is involved in protein folding and degradation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Upregulates FBXO10 activity by inhibiting PP2A, a regulator of various signaling pathways. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
Upregulates FBXO10 by reducing oxidative stress-related protein degradation, functioning as an ROS scavenger. | ||||||